Publications by authors named "Laura Pavan"

Claim this Profile
B
Belamaf: Is Renal Toxicity an Overlooked Side Effect?
Gisella Vischini, Paola Tacchetti, Laura Pavan, Simona Barbuto, Daniele Vetrano

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic stratification of standard risk multiple myeloma defined by revised international scoring system.
Gregorio Barilà, Laura Bonaldi, Annalisa Martines, Anna Pascarella, Susanna Vedovato, Laura Pavan

Leuk Lymphoma· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Update of the Appropriate Sequencing for Salvage Therapies in Multiple Myeloma.
Gregorio Barilà, Francesca Rezzonico, Laura Pavan, Alessandro Corso, Renato Zambello

Mediterr J Hematol Infect Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real-world retrospective-prospective analysis of efficacy and safety of combined ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma: The northern Italy experience.
Anna Furlan, Michele Cea, Laura Pavan, Monica Galli, Cristina Clissa

Cancer Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real-life study of daratumumab-bortezomib-dexamethasone (D-VD) in lenalidomide exposed/refractory multiple myeloma patients: a report from the Triveneto Myeloma Working Group.
Gregorio Barilà, Francesca Maria Quaglia, Anna Furlan, Norbert Pescosta, Angela Bonalumi, Laura Pavan

Ann Hematol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Waldenström Macroglobulinemia in Very Elderly (≥75-year-old) Patients: A 33-year-retrospective Cohort Study in an Italian University Hospital.
Nicolò Danesin, Mariella Lo Schirico, Greta Scapinello, Angela Grassi, Marcello Riva, Laura Pavan

Hemasphere· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies.
Francesco Angotzi, Marco Petrella, Tamara Berno, Gianni Binotto, Giorgia Bonetto, Laura Pavan

Front Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging minimal residual disease evaluation in multiple myeloma using [F]FDG PET/MRI.
Gregorio Barilà, Filippo Crimì, Massimiliano Arangio Febbo, Laura Pavan, Susanna Vedovato

Leuk Lymphoma· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma.
Francesca Bonello, Serena Rocchi, Gregorio Barilà, Michela Sandrone, Marco Talarico, Laura Pavan

Front Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Induced Cytotoxic T-Cell Modulation in Multiple Myeloma Patients.
Gregorio Barilà, Laura Pavan, Susanna Vedovato, Tamara Berno, Mariella Lo Schirico

Front Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stat3 mutations impact on overall survival in large granular lymphocyte leukemia: a single-center experience of 205 patients.
Gregorio Barilà, Antonella Teramo, Giulia Calabretto, Cristina Vicenzetto, Vanessa Rebecca Gasparini, Laura Pavan

Leukemia· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of the true hyperdiploid multiple myeloma subset by combining conventional karyotyping and FISH analysis.
Gregorio Barilà, Laura Bonaldi, Angela Grassi, Annalisa Martines, Albana Liço, Laura Pavan

Blood Cancer J· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicentre survey to explore current survival of patients with acute myeloid leukaemia who failed induction chemotherapy.
Davide Lazzarotto, Anna Candoni, Gianpaolo Nadali, Laura Pavan, Federica Lessi

Eur J Haematol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The chromatin remodelling component SMARCB1/INI1 influences the metastatic behavior of colorectal cancer through a gene signature mapping to chromosome 22.
Massimo Pancione, Andrea Remo, Caterina Zanella, Lina Sabatino, Arturo Di Blasi, Laura Pavan

J Transl Med· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity.
Laura Quotti Tubi, Carmela Gurrieri, Alessandra Brancalion, Laura Bonaldi, Roberta Bertorelle, Laura Pavan

J Hematol Oncol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein response.
Sabrina Manni, Alessandra Brancalion, Laura Quotti Tubi, Anna Colpo, Laura Pavan

Clin Cancer Res· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful control of Blastoschizomyces capitatus infection in three consecutive acute leukaemia patients despite initial unresponsiveness to liposomal amphotericin B.
Fausto Adami, Marino Scarin, Luigi Pescarini, Gianni Binotto, Laura Pavan

Mycoses· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death.
Francesco Piazza, Sabrina Manni, Laura Quotti Tubi, Barbara Montini, Laura Pavan

BMC Cancer· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The DePuy Proxima hip: a short stem for total hip arthroplasty. Early experience and technical considerations.
Stefano Ghera, Laura Pavan

Hip Int· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Periprosthetic DXA after total hip arthroplasty with short vs. ultra-short custom-made femoral stems: 37 patients followed for 3 years.
Carlina V Albanese, Francesco S Santori, Laura Pavan, Ian D Learmonth, Roberto Passariello

Acta Orthop· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Adult acute lymphoblastic leukemia with central nervous system involvement: an overview].
Xavier Thomas, Laura Pavan, Quoc-Hung Le

Bull Cancer· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-cell type lymphoproliferative disease of granular lymphocytes (LDGL) is equipped with a phenotypic pattern typical of effector cytotoxic cells.
Ilenia Baesso, Laura Pavan, Elisa Boscaro, Marta Miorin, Monica Facco

Leuk Res· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis